Samir Ounzain

Samir Ounzain

Company: HAYA Therapeutics

Job title: Co-founder, CEO & Board Director


Transformational RNA-Guided Programmable Therapeutics to Target Disease-Causing Cell-States 1:30 pm

LncRNAs as druggable ‘information processing units’ for programming cell-states High priority lncRNA target discovery in fibrosis associated cell-state changes Considerations for lncRNA ‘druggability’Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.